Wi-LAN Inc - US listing  

(Public, NASDAQ:WILN)   Watch this stock  
Find more results for WILN
3.87
+0.06 (1.57%)
Aug 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.80 - 3.88
52 week 2.85 - 4.61
Open 3.80
Vol / Avg. 111,039.00/116,283.00
Mkt cap 465.47M
P/E 77.40
Div/yield     -/4.74
EPS 0.05
Shares 120.10M
Beta 1.47
Inst. own     -
Oct 29, 2014
Q3 2014 WiLan Inc Earnings Conference Call (Tentative) - 10:00AM EDT - Add to calendar
Oct 29, 2014
Q3 2014 WiLan Inc Earnings Release (Tentative) Add to calendar
Sep 4, 2014
WiLan Inc at Liolios Group Gateway Conference - 12:30PM EDT - Add to calendar
Aug 14, 2014
WiLan Inc at Canaccord Genuity Growth Conference
Jul 30, 2014
Q2 2014 WiLan Inc Earnings Conference Call
Jul 30, 2014
Q2 2014 WiLan Inc Earnings Release
Jun 18, 2014
WiLan Inc Annual Shareholder Meeting
More events from DailyFinance »    

Address

Suite 608, 11 Holland Avenue
OTTAWA, ON K1Y 4S1
Canada
+1-613-6884900 (Phone)
+1-613-6884894 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

WiLAN Inc. (WiLAN), is a licensing company. WiLAN develops, acquires, and licenses a range of intellectual property that drives products in communications and consumer electronics markets. Through both internal research and development and acquisitions from third parties, the Company has acquired intellectual property in the form of patents and patent applications in many countries that it has licensed to more than 255 companies in telecommunications markets around the world. As of December 31, 2011, it had a portfolio of approximately 3,000 patents, including issued and pending patents and foreign equivalents. In June 2013, it acquired a portfolio of patents from Cypress Semiconductor Corporation. In November 2013, it acquired a portfolio of semiconductor patents from IXYS CH GmbH related to microcontroller technology. In June 2014, the Company announced that a subsidiary has acquired a portfolio of medical patents that relate to Stent technology.

Officers and directors

W. Paul McCarten Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
James Douglas Skippen President, Chief Executive Officer, Chief Legal Officer, Director
Age: 51
Bio & Compensation  - Reuters
Michael Shaun McEwan Chief Financial Officer
Bio & Compensation  - Reuters
Kenneth Stanwood President of Cygnus Broadband, Inc.
Bio & Compensation  - Reuters
Michael B. Vladescu Chief Operating Officer
Bio & Compensation  - Reuters
Andrew Parolin Senior Vice President - Licensing
Bio & Compensation  - Reuters
Mark Schneider Senior Vice President, Business Unit Leader and Senior Patent Counsel
Bio & Compensation  - Reuters
Doug MacCrae Vice President - Finance
Bio & Compensation  - Reuters
Prashant Watchmaker Vice President - Corporate Legal & Corporate Secretary
Bio & Compensation  - Reuters
Marc Frechette Vice President, Business Unit Leader and Senior Patent Counsel
Bio & Compensation  - Reuters